OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced that it has established a US subsidiary and made initial key recruitments.

A patient with a large cranial tumor was successfully operated by neurosurgeons at Uppsala University Hospital in Sweden during the summer of 2017. During the surgery, the majority of the patient's cranium was substituted with a personalized implant from OssDsign. The implant material is the result of research carried out at Uppsala University.